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ABSTRACT 
 
Background: Release of neurotransmitters from secretomotor neurons in the intestinal mucosa is 
well known to acutely promote intestinal Cl- and fluid secretion through activation of epithelial G 
protein-coupled receptors (GPCRs). In the present study we examined if GPCR activation might 
also have more long-term consequences for epithelial secretory function. Methods: Cl- secretion 
was measured as changes in short-circuit current across voltage-clamped T84 colonic epithelial 
cells. Protein expression was measured by western blotting and intracellular Ca2+ levels by Fura-
2 fluorescence. Key Results: Treatment of T84 cells with the cholinergic GqPCR agonist, 
carbachol (CCh; 100µM), rapidly stimulated Cl- secretory responses. However, 24 hrs after acute 
treatment with CCh, responses to subsequent challenge with the agonist were attenuated by 43.1 
± 5.5% (n = 29; p < 0.001). CCh-pretreatment did not alter responses to another GqPCR agonist, 
histamine, or to thapsigargin or forskolin which elevate intracellular Ca2+ and cAMP 
respectively. This chronically-acting antisecretory.mechanism is not shared by neurotransmitters 
that act at GsPCRs. Conditioned medium from CCh-pretreated cells mimicked the chronic 
antisecretory action of the agonist, suggesting the involvement of an epithelial-derived soluble 
factor. Acute exposure to agonist did not chronically alter surface expression of muscarinic M3 
receptors but inhibited intracellular Ca2+ mobilization upon subsequent agonist challenge. 
Conclusions and Inferences: These data reveal a novel, chronically-acting, antisecretory 
mechanism that serves to downregulate epithelial secretory responses upon repeated exposure to 
agonists of GqPCRs. This mechanism involves release of a soluble factor that uncouples receptor 
activation from downstream prosecretory signals.  
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INTRODUCTION 
 
The intestinal epithelium functions to provide a barrier against the uptake of harmful substances 
from the lumen into the body and to transport fluid and electrolytes to and from the intestinal 
contents. Fluid absorption is driven by cation absorption while secretion is driven primarily by 
Cl- ion secretion. Absorption normally predominates, allowing conservation of the large volumes 
of fluid that enter the intestine each day, but secretion is also ongoing and is necessary for normal 
hydration of the mucosal surface and maintenance of epithelial barrier function. However, in 
many pathological conditions the delicate balance between absorptive and secretory processes 
can be disrupted leading to the clinical manifestation of diarrhea (1).  
 
The enteric nervous system (ENS) plays a critical role in regulating intestinal secretory function 
(2-4). Secretomotor nerve terminals originating in the submucosal plexus are found closely 
opposed to the epithelium throughout the intestinal tract. Upon activation these nerves release an 
array of neurotransmitters capable of evoking secretory responses, most of which act by binding 
to cell surface G protein coupled receptors (GPCRs). Activation of these receptors in turn brings 
about stimulation of intracellular signalling cascades which ultimately interact with the epithelial 
transport machinery to induce Cl- secretion. The most important receptors with respect to 
stimulation of Cl- secretion are GqPCRs which are linked to activation of phospholipase C, 
elevations in intracellular Ca2+ and activation of protein kinase C (PKC) and GsPCRs which 
stimulate cAMP accumulation (5). In animal and cell culture models Cl- secretory responses to 
neurotransmitters that act at GqPCRs, for example acetylcholine, are typically rapid in onset and 
transient while those to GsPCRs agonists, such as vasoactive intestinal polypeptide (VIP), are 
more gradual in onset and sustained. This suggests that mechanisms exist within epithelial cells 
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that serve to limit the extent and duration of responses to agonists of GqPCRs and indeed a 
number of such antisecretory effectors have been identified including PKC (6, 7), inositol 
tetrakisphosphate (8), and mitogen-activated protein kinases (9, 10). In addition, in vivo, specific 
re-uptake mechanisms and the actions of metabolising enzymes, such as acetylcholine esterase, 
ensure that the half life of transmitters within the neuroepithelial junction is kept short. Thus, the 
combined actions of intracellular and extracellular regulatory mechanisms dictate the extent and 
duration of epithelial secretory responses to neurotransmitters that act at Gq PCRs.   
 
While the mechanisms underlying the immediate actions of neurotransmitters on epithelial 
transport have been extensively investigated over the years, to date, there have been no reported 
studies of long-term consequences of neurotransmitter exposure on epithelial transport function. 
To address this gap in our knowledge we sought to investigate if acute exposure to 
neurotransmitters that act at GPCRs has long-term effects on intestinal epithelial secretory 
function. We employed a reductionist approach in which the long-term effects of acute exposure 
to prototypical Gq and GsPCR agonists on Cl- secretion across cultured colonic epithelial cells 
were investigated. Our data reveal a novel, chronically acting, antisecretory mechanism that 
downregulates epithelial responsiveness to repeated exposure to agonists of Gq PCRs. 
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MATERIALS AND METHODS: 
 
Materials: Carbachol, forskolin, histamine, thapsigargin, phorbol myristyl acetate, vasoactive 
intestinal polypeptide and HRP-conjugated secondary antibodies were obtained from Sigma-
Aldrich, UK. Tyrphostin AG1478, anti-TGF-α antibody and GM6001 were obtained from 
Calbiochem, San Diego, CA. Anti-muscarinic M3 receptor antibody was from Santa Cruz 
Biotechnology, Santa Cruz, CA.  All other reagents were of analytical grade and were obtained 
commercially. 
 
Cell Culture: The colonic epithelial cell line, T84, was cultured on petri dishes in DMEM/Hams F12 
media (1:1) (Sigma-Aldrich, UK) supplemented with 5% newborn calf serum (HyClone, Logan, 
Utah, USA). Cells were cultured in an atmosphere of 5% CO2 at 370C with medium changes every 3 
- 4 days. For Ussing chamber/voltage clamp studies, approximately 5 x 105 cells were seeded onto 
12 mm Millicell-HA Transwells (Millipore, Bedford, MA). For western blotting/biotinylation 
experiments, approximately 106 cells were seeded onto 30 mm Millicell-HA Transwells. Cells 
seeded onto Millicell filters were cultured for 10 - 15 days prior to use. Under these conditions T84 
cells develop the polarized phenotype of native epithelial cells and are widely considered to be  
among the best models for reductionist studies of Cl- epithelial secretion. 
 
Electrophysiological Measurements: After culture for 10 – 15 days on filter supports, T84 cell 
monolayers were washed in serum free medium and allowed to equilibrate for 30 min. Cells were 
then treated on the basolateral side with agonists at various concentrations and for various periods of 
time as noted in the figure legends. After agonist-treatment monolayers were mounted in Ussing 
Page 5 of 30 Neurogastroenterology and Motility
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
    Toumi     6 
 
chambers (aperture = 0.6 cm2), voltage-clamped to zero potential difference, and monitored for 
changes in Isc (∆Isc) using a VCC MC8 Voltage Clamp (Physiological Instruments, San Diego, CA). 
Under such conditions secretagogue-induced changes in Isc across T84 monolayers are wholly 
reflective of changes in electrogenic chloride secretion (11). Isc measurements were carried out in 
Ringer’s solution containing (in mM): 140 Na+, 5.2 K+, 1.2 Ca2+, 0.8 Mg2+, 119.8 Cl-, 25 HCO3-, 2.4 
H2PO42-, and 10 glucose. Results were normalized and expressed as ∆Isc (µA/cm2). 
 
Western Blotting: T84 cell monolayers were washed (x3) in serum free medium and allowed to 
equilibrate for 30 min at 370C. Cells were then treated with agonists as noted in the figure legends 
after which they were washed and allowed to recover in serum-free medium. Monolayers were then 
washed (x2) with ice-cold PBS and lysed in ice-cold lysis buffer (500 µl) (consisting of 1% Triton-
X-100, 1 mM NaVO4, 1 µg/ml leupeptin, 1 µg/ml pepstatin, 1 µg/ml antipain, 1 mM NaF, 1 mM 
EDTA, and 100 µg/ml phenylmethylsulfonyl fluoride in PBS). Cells were then incubated at 40C for 
45 min, scraped into microcentrifuge tubes, and centrifuged at 12,000 rpm for 10 min. After 
centrifugation, the pellet was discarded and samples were adjusted so that they contained equal 
amounts of protein. Samples were then mixed with 2X gel loading buffer (50 mM Tris, pH 6.8, 2% 
SDS, 100 mM dithiothreitol, 0.2% bromophenol blue, 20% glycerol), boiled for 3 min, and proteins 
separated by SDS-PAGE. Separated proteins were transferred to PVDF membrane after which the 
membrane was washed in 1% blocking buffer for 30 min, followed by incubation with the 
appropriate dilution of primary antibody in 1% blocking buffer for 60 min. This was followed by 
washing (x5) in Tris buffered saline with 1% tween (TBST). HRP-conjugated secondary antibodies 
were then added to the membrane in 1% blocking buffer, and allowed to incubate for an additional 
30 min. After further washing (x5) in TBST, immunoreactive proteins were detected using an ECL 
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detection kit (Amersham Lifesciences, UK) and exposure of the membrane to X-ray film. 
Quantitation of protein phosphorylation was determined by densitometry using Scion image 
software. 
 
Cell Surface Biotinylation: The protocol used was based on one previously described (7). 
Following treatment the cells were washed three times in ice-cold PBS. Freshly prepared 
biotinylation buffer (1mg/ml Sulfo-NHS-Biotin (Pierce) in PBS) was added to the basolateral 
side of the cells. Cells were then incubated at 40C for 15 minutes on a rotating platform after 
which the buffer was removed and a replaced with a second fresh aliquot. After an additional 15 
minutes incubation, the cells were washed twice with PBS and then incubated with a quenching 
reagent (100 mM glycine in PBS). The cells were then washed with PBS and lysed in Triton lysis 
buffer for 45 minutes on ice. The lysate was centrifuged at 14,000 rpm for 6 minutes and the 
protein concentration of the supernatant was determined and normalized. The samples were then 
precipitated on a rotator overnight at 4°C with 100 µl of streptavidin-agarose beads (Pierce). The 
beads were then washed three times in lysis buffer and 40 µl of 2X laemmli buffer (Sigma-
Aldrich, UK) was added. The samples were boiled at 95°C for 5 minutes and subjected to SDS-
PAGE analysis.  M3R was detected by western blotting as described above.   
 
Intracellular Ca2+ Imaging: After pretreatment with CCh (100 µM; 15 min) T84 cells grown on 
glass coverslips were allowed to recover for 24 hrs in serum free medium. The cells were then 
washed and loaded with 5 µM Fura-2/AM (dissolved in 0.01% Pluronic F-127 plus 0.1% DMSO 
in physiological salt solution (140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 10 mM D-glucose, and 10 
mM HEPES-trimethylamine, pH 7.4) at room temperature for 30 min. Coverslips were then 
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washed and mounted in a perfusion chamber on a Nikon microscope stage. Cells were perfused 
with normal physiological salt solution for 5 min before adding CCh (100 µM) to the perfusing 
solution. The ratio of Fura-2 fluorescence with excitation at 340 or 380 nm (F340/380) was 
measured every 3 s and images were captured using an intensified CCD camera (ICCD200) and a 
MetaFluor Imaging System (Molecular Devices Corporation, Sunnyvale, CA, USA). 
 
Statistical Analysis: All data are expressed as mean ± sem for a series of n experiments. Students' t-
tests were used to compare paired data. One-way analysis of variance with the Student-Neuman-
Keuls post-test was used when three or more groups of data were compared. p values ≤ 0.05 were 
considered to be statistically significant. 
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RESULTS 
 
Acute stimulation with CCh chronically inhibits secretory responses to subsequent agonist 
exposure. We first investigated acute and long-term actions of CCh on epithelial secretory 
responses. CCh is an analog of acetylcholine that acts at Gq-coupled M3 receptors on intestinal 
epithelial cells. In line with several previous studies we found that acute exposure of voltage-
clamped T84 cell monolayers to CCh evoked rapid onset and transient Isc responses (Figure 1A).  
These responses have previously been previously characterized to be wholly due to electrogenic 
Cl- secretion (12). We next examined if acute exposure to CCh might have more long-term 
consequences for epithelial secretory function. T84 cell monolayers were stimulated with CCh 
(100 µM) for 15 min after which time they were washed and allowed to recover for 24 hrs in 
serum free medium. Monolayers were then mounted in Ussing chambers and Isc responses to a 
2nd challenge with CCh (100 µM) were measured. As shown in Figure 1A, acute pretreatment 
with CCh significantly downregulated Isc responses to subsequent challenge with the agonist 24 
hrs later. Control responses to CCh were 37.3 ± 2.5 µA/cm2 compared to 19.6 ± 1.7 µA/cm2 in 
cells that were pretreated with the agonist (n = 25; p < 0.001). The concentration-dependence for 
CCh-pretreatment in chronically downregulating secretory responses to subsequent agonist 
challenge was similar to that for its effects in acutely stimulating Cl- secretion (Figure 1B) with 
the threshold for both effects occurring between 1 – 10 µM and maximal responses being 
observed for both effects at 1 mM. We next analyzed the time-course over which acute (15 min) 
stimulation with CCh alters subsequent secretory responses to agonist exposure. Pretreatment 
with CCh acutely inhibited subsequent secretory responses to the agonist when measured after 1 
hr. However, within 6 hrs after initial challenge with CCh, secretory responses to a second 
challenge had recovered almost to control levels. This was then followed by a prolonged loss of 
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secretory responsiveness to subsequent CCh challenge that was maximal after 24 hrs. In all 
subsequent experiments pretreatment of the cells with CCh (100 µM) was carried out for 15 min 
with secretory responses being measured 24 hrs later. Under these conditions, pretreatment with 
CCh did not alter basal Isc or conductance. The basal conductance of T84 cell monolayers 24 hrs 
after pretreatment with CCh was 1.40 ± 0.15 mS/cm2 compared to 1.37 ± 0.13 mS/cm2 in control 
monolayers. Pretreatment with CCh (100 µM; 15 mins) did not inhibit secretory responses to 
either thapsigargin (TG; 2 µM) or forskolin (FSK; 10 µM) when measured 24 hrs later. 
Responses to TG and FSK in CCh-pretreated cells were 143.8 ± 32.9 µA/cm2 (n = 8) and 134.5 ± 
18.5% (n = 8) µA/cm2 of those in control cells, respectively. 
 
Chronic downregulation of secretory responses upon repeated agonist exposure is specific to 
GqPCRs. We next went on to examine if the chronic downregulation of secretory responses seen 
upon repeated agonist stimulation is specific for muscarinic M3 receptors or if it is phenomenon 
common across the GPCR superfamily. Thus, we examined acute and chronic actions of the 
immune cell mediator, histamine, on secretory function. Similar to CCh, we found that in cells 
acutely pretreated histamine (100 µM; 15 min), subsequent secretory responses to the agonist 
were significantly attenuated when measured 24 hrs later. Control responses to histamine were 
13.5 ± 1.3 µA/cm2 compared to 9.3 ± 1.0 µA/cm2  in cells that were pretreated with the agonist  
(n = 8; p < 0.001). However, in similar experiments acute exposure to vasoactive intestinal 
polypeptide (VIP; 100 nM; 15 min), a neurotransmitter that acts at GsPCR receptors, did not 
chronically alter subsequent responses to VIP exposure (Figure 2B). Furthermore, we found that 
in cells acutely pretreated with CCh, subsequent responses to histamine were unaltered (Figure 
2C), while in cells pretreated with histamine, subsequent responses to CCh were not affected 
when measured 24 hrs later (Figure 2D). 
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Elevations in intracellular Ca2+ or activation of PKC does not chronically alter epithelial 
secretory responses. Ligand binding to GqPCRs is linked to activation of phospholipase C which 
cleaves membrane phospholipids to yield IP3 and diacylglycerol. IP3 then releases Ca2+ from 
intracellular stores while diacylglycerol serves to activate various isoforms of PKC. To begin to 
elucidate mechanisms underlying chronic downregulation of secretory responses, we examined if 
activation of either of these signaling pathways alone could mimic the antisecretory effects 
observed upon repeated GqPCR stimulation. Thapisgargin (TG), which inhibits the endoplasmic 
reticulum Ca2+ ATPase pump, was used to elevate intracellular Ca2+ and the phorbol ester, 
phorbol myristyl acetate (PMA) was used to activate PKC. We found that acute pretreatment with 
either TG (2 µM; 30 min) or PMA (100 nM; 30 min) alone did not alter subsequent responses to 
CCh 24 hrs later (Figure 3). In further experiments we found that pretreatment of the cells with a 
general inhibitor of PKC, chelerythrine chloride (10 µM), did not restore secretory responses 
after repeated exposure to CCh. 
 
The chronic antisecretory action of GqPCR activation is mediated by a soluble factor but not by 
EGFr transactivation. We next investigated if the loss of epithelial secretory responsiveness that 
occurs upon repeated GqPCR agonist exposure could be mediated by the production of an 
epithelial-derived soluble factor. In these experiments cells were pretreated with CCh (100 µM) 
for 15 min and after allowing them to recover for 24 hrs the basolateral culture medium was 
collected and Isc responses to a second challenge with CCh were measured in Ussing chambers. 
Virgin monolayers of cells were then exposed to the basolateral media collected from control and 
CCh-pretreated cells. After 24 hrs incubation, these conditioned medium-treated cells were also 
voltage clamped and Isc responses to CCh were measured. As shown in figure 4A, conditioned 
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medium from CCh-pretreated cells was equally effective to the agonist itself in inhibiting 
subsequent secretory responses to CCh challenge. Since, these data suggest that an epithelial-
derived soluble factor is involved we went on to investigate if ligand-dependent transactivation of 
the EGF might play a role in mediating the antisecretory effects of GqPCR activation. However, 
as shown in Figures 4 B - C. Neither the EGFr inhibitor, AG1478 (100 nM), the general 
metalloprotease inhibitor, GM6001 (10 µM), nor a blocking antibody to TGF-α (5 µg/ml), could 
restore secretory responses to CCh in monolayers that had been acutely pretreated with the 
agonist 24 hrs previously. 
 
Acute stimulation with CCh does not chronically alter M3 receptor expression but uncouples the 
receptor from elevations in intracellular Ca2+. Finally, we investigated if altered cellular or 
surface expression of the M3 receptor or if altered coupling of the receptor to downstream 
effectors might underlie the attenuation of secretory responses that occurs with repeated agonist 
exposure. Using western blotting and cell surface biotinylation we found that in cells pretreated 
with CCh neither total cellular nor basolateral surface expression of the M3R was altered after 24 
hrs (Figure 5A - B). As a measure of receptor coupling to prosecretory signaling pathways we 
analyzed intracellular Ca2+ levels by Fura2 fluorescence. These experiments revealed that, similar 
to its effects on Cl- secretion, acute pretreatment of the cells with CCh chronically attenuated 
their capacity to mobilize intracellular Ca2+ upon subsequent agonist exposure (Figure 5C). 
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DISCUSSION 
 
Upon activation the enteric nervous system releases an array of neurotransmitters that exert their 
effects through activation of GPCRs on the basolateral side of the epithelial cells. Extensive 
research has been carried to characterize the roles that these receptors play in regulating epithelial 
functions, including cell growth and cytokine synthesis (13-15). Neurotransmitters that act at 
either Gq or GsPCRs have also been well-documented to rapidly induce transpeithelial Cl- 
secretion, an effect that in vivo causes enhanced fluid secretion into the intestinal lumen (5). 
Despite their well-established roles in acutely promoting intestinal secretory function, potential 
long-term consequences of neurotransmitters that act at GPCRs on epithelial secretory function 
are unknown. In the current study we have begun to address this gap in our knowledge and 
present data to show that acute exposure to GPCR agonists chronically inhibits epithelial 
secretory responses to subsequent agonist exposure. Furthermore, these effects are specific for 
agonists that act at the Gq class of GPCR.  
 
Due to the presence of specific reuptake mechanisms and metabolic enzymes, released 
neurotransmitters do not persist in the neuroepithelial junction in vivo and their contact time with 
epithelial cells is likely to be brief. With this in mind, we adopted the approach of investigating 
the long-term consequences of relatively acute agonist exposure on epithelial secretory function. 
We found that acute treatment of colonic epithelia with CCh, a stable analog of the most 
prominent intestinal neurotransmitter, acetylcholine, induced a time-dependent biphasic decrease 
in responsiveness to subsequent agonist exposure. An early attenuation of secretory responses 
occurred up to 3 hrs after initial agonist exposure. Such early inhibitory effects have been 
previously described and are due to depletion of intracellular second messengers and activation of 
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antisecretory mechanisms, such as transport protein internalization and the generation of inositol 
tetrakisphosphate (7, 8, 16). However, within 6 hrs these relatively short-term antisecretory 
signals had abated as evidenced by the observation that responses to a second challenge with CCh 
were comparable to those in control cells. Intriguingly, at time points after 6 hrs we observed a 
second, slow onset, and sustained loss of epithelial responsiveness to a second challenge with 
agonist. This chronic antisecretory effect was not due to a loss of cell viability since responses to 
thapsigargin and forskolin, which are receptor independent activators of the Ca2+ and cAMP-
dependent secretory pathways respectively, were not inhibited. Similarly, basal electrical 
parameters of epithelial monolayers were not chronically altered in cells pretreated with CCh.  
 
The generation of chronically acting antisecretory signals after GqPCR activation appears to be 
highly specific. Similar to our observations with CCh, an M3R agonist, pretreatment of T84 cells 
with an immune cell-derived GqPCR agonist, histamine, also attenuated subsequent responses to 
histamine challenge. In contrast, pretreatment with a neurotransmitter that acts at GsPCRs, VIP, 
did not chronically alter responses to subsequent challenge with this agonist. Thus, the 
attenuation of epithelial secretory responsiveness that occurs upon repeated agonist exposure 
appears to be specific for those that act at the GqPCR subclass. Interestingly, pretreatment of 
epithelial monolayers with histamine did not chronically alter responses to CCh, or vice versa, 
suggesting that this antisecretory mechanism exerts its actions in a receptor specific manner and 
that heterologous receptor desensitization, which can be a feature of GPCR activation in some 
systems (17, 18), does not occur. Thus, on the basis of these data one would expect that in vivo, 
release of acetylcholine from secretomotor neurons would render the epithelium chronically 
refractory to subsequent cholinergic stimulation, whereas responses to other GqPCR agonists, 
such as histamine released from mast cells, would remain unaltered. 
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Agonists that act at GqPCRs classically initiate cellular signaling through activation of 
phospholipase C and generation of IP3 and DAG from membrane phospholipids. These 
messengers then go on to bring about elevations in intracellular Ca2+ and activation of PKC, 
respectively. Since PKC has been shown to be important in other systems in mediating receptor 
desensitization to GPCR agonists (19-21), we examined if activation of either of these pathways 
alone could induce long-term attenuation of epithelial secretory capacity. For these experiments 
we used thapsigargin and PMA, which act in a receptor-independent manner to elevate 
intracellular Ca2+ and PKC, respectively. Although both agonists were used under conditions we 
have previously shown to effectively elevate intracellular Ca2+ and to activate PKC (9, 22), 
neither altered subsequent secretory responses to CCh. Furthermore, a general inhibitor of PKC, 
chelerythrine chloride, did not prevent the attenuation of responses that occurs upon repeated 
CCh exposure. These data suggest that neither depletion of Ca2+ stores, elevation of cytosolic 
Ca2+ or activation of PKC alone are sufficient signals to induce a chronic hyposecretory 
phenotype. 
 
Our previous studies have identified a GqPCR-induced antisecretory signaling mechanism that is 
mediated by EGFr and MAPK activation and that serves to acutely downregulate the extent of 
Ca2+-dependent secretory responses (9, 23). Transactivation of the EGFr is mediated by Src-
induced activation of a metalloprotease which cleaves TGF-α from the membrane with the 
growth factor then acting in an autocrine fashion to activate the EGFr. We hypothesized that this 
pathway might also be involved in the more long-term antisecretory action that occurs upon 
repeated agonist exposure. Thus, to determine if an epithelial-derived soluble factor is involved, 
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we analyzed secretory responses to CCh in cells treated with conditioned medium collected from 
monolayers that were acutely treated with the agonist. Interestingly, prolonged exposure to 
conditioned medium from CCh-pretreated cells was as effective as the agonist itself in 
attenuating the subsequent responses to CCh. Thus, our data support the idea that an epithelial-
derived soluble factor is involved. To determine if this factor acts through EGFr activation we 
used a range of inhibitors that we have previously shown to effectively inhibit EGFr 
transactivation in response to CCh (9, 23). However, in these experiments we found that neither 
the EGFr inhibitor, tyrphostin AG1478, the metalloprotease inhibitor, GM6001, nor a blocking 
antibody to TGF-α could reverse the attenuation of epithelial secretory responsiveness that 
occurs upon repeated agonist exposure. Thus, although colonic epithelial cells have the capability 
to produce soluble EGFr ligands, such as TGF-α, in response to GqPCR agonists (23, 24), our 
data suggest that the epithelial-derived factor that chronically inhibits responses to repeated 
agonist challenge acts independently of the  EGFr. Experiments are currently underway to 
determine the identity of the soluble factor involved.  
 
Prolonged exposure to agonists of GqPCRs typically leads to their desensitization through 
receptor internalization and degradation (25-27). However, previous studies have not addressed 
whether acute stimulation of GqPCRs in epithelial cells might also lead to a prolonged loss of 
receptor expression, thereby leading to an attenuation of agonist-induced responses. Here we 
found that acute pretreatment of epithelial monolayers with CCh did not chronically alter either 
total cellular or surface expression of the muscarinic M3R. This suggests that, in contrast to the 
alterations in receptor trafficking and expression that occur with prolonged GPCR exposure, 
acute exposure to GqPCRs agonists does not chronically alter receptor expression in intestinal 
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epithelia. They also suggest that the loss of secretory responsiveness that occurs upon repeated 
agonist exposure is not due to a loss of cell surface receptor expression but rather to an 
uncoupling of receptors from downstream prosecretory signaling pathways. This hypothesis is 
supported by our observations that in cells acutely pretreated with CCh, mobilization of 
intracellular Ca2+ in response to subsequent agonist challenge was significantly attenuated. This 
inhibition of Ca2+ release is not due to depletion of internal stores since secretory responses to 
other Ca2+-dependent agonists, such as TG and histamine, are not altered by prior treatment with 
CCh. Thus, our data suggest that the chronically acting antisecretory mechanism impinges on 
GqPCR-induced prosecretory pathways at a point distal to agonist/receptor binding but proximal 
to release of Ca2+ from stores. 
 
In summary, we have identified a novel, chronically acting, antisecretory mechanism that limits 
the capacity of epithelial cells to evoke secretory responses upon repeated exposure to 
neurotransmiters that act at Gq, but not GsPCRs. This mechanism is not due to receptor 
downregulation or sequestration but is mediated by an epithelial-derived soluble factor that 
uncouples receptor activation from downstream prosecretory signals. The 
physiological/pathophysiological significance of our findings is unclear and raises several 
interesting questions. Perhaps, most importantly why do epithelial cells respond in such a 
complex manner to agonists of GqPCRs? At this point we can only speculate on the answer to this 
question but it seems likely that in vivo such a chronically-acting antisecretory mechanism would 
serve to limit epithelial secretory capacity therefore preventing the onset of diarrhea in conditions 
where enteric neuronal activity is enhanced. Indeed, previous studies in vivo support this 
hypothesis since colonic tissues from mice with IBD are hyporesponsive to cholinergic 
stimulation without alterations in M3R expression (28-30). In future studies we aim to more fully 
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investigate the molecular mechanisms involved in chronic downregulation of epithelial 
responsiveness by GqPCR agonists with the hope that this will yield a greater understanding of 
the mechanisms by which enteric neurotransmitters regulate intestinal fluid transport in health 
and disease. 
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FIGURE LEGENDS 
 
Figure 1: Acute exposure to CCh chronically inhibits secretory responses to subsequent 
agonist exposure. A) Cells were acutely treated with basolateral CCh (100 µM for 15 mins) and 
were then washed and allowed to recover in serum free medium for 24 hrs. Cells were then 
mounted in Ussing chambers and Cl- secretory responses to a second challenge with CCh (100 
µM) were measured as changes in Isc (n = 25). B) Cells were acutely exposed to different 
concentrations of CCh (1 µM - 1 mM; 15 mins) and Cl- secretory responses to a second challenge 
with CCh (100 µM) were measured 24 hrs later (n = 3). The concentration-dependence of the 
chronic antisecretory effect of CCh is plotted alongside that of its acute prosecretory actions for 
comparison (n = 3). C) Cells were acutely treated with CCh (100 µM; 15 min) and were then 
allowed to recover for various periods (1 - 24 hrs) in serum free medium before Cl- secretory 
responses to a second challenge with CCh were measured (n = 3 - 8 for each time point; * p < 
0.05, ***p < 0.001 compared to control cells). 
 
Figure 2: Chronic downregulation of secretory responses upon repeated agonist exposure is 
specific to GqPCRs. A) Monolayers of T84 cells were pretreated with histamine (100 µM) for 15 
mins, washed and allowed to recover for 24 hrs before Cl- secretory responses to a second 
challenge with histamine (100 µM) were measured (n = 8). B)  T84 cells were pretreated with VIP 
(100 nM) for 15 mins and after recovery for 24 hrs Cl- secretory responses to a second challenge 
with VIP (100 nM) were measured (n = 3). C and D) T84 cell monolayers were acutely pretreated 
with histamine or CCh (100 µM; 15 min) and after recovery in serum free medium for 24 hrs, Isc 
responses to either C) CCh (100 µM; n = 6) or D) histamine (100 µM; n = 6) were measured in 
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Ussing chambers. Asterisks denote significant differences from control cells; *p < 0.05, *** p < 
0.001. 
 
Figure 3: Elevations in intracellular Ca2+ or activation of PKC does not chronically alter 
secretory responses to CCh. Monolayers of T84 cells were acutely pretreated with either CCh 
(100 µM; 15 min), thapsigargin (2 µM; 30 min), PMA (100 nM; 30 min) or a combination of TG 
and PMA. After washing and recovery for 24 hrs in serum free medium, cell monolayers were 
mounted in Ussing chambers and secretory responses to CCh (100 µM) were measured (n = 3). 
B) Cells were pretreated with CCh (100 µM; 15 mins) either in the absence or presence of the 
general PKC inhibitor, chelerythrine chloride (10 µM), or vehicle for controls. Cells were then 
washed and maintained in chelerythrine chloride for 24 hrs before secretory responses to a 
second challenge with CCh (100 µM) were measured in Ussing chambers (n = 5). Asterisks 
denote significant differences from control cells; **p < 0.01. 
 
Figure 4: The chronic antisecretory effects of GqPCR activation are mediated by a soluble 
factor but not by EGFr transactivation. A) Monolayers of T84 cells were treated with CCh 
(100 µM; 15 min), washed, and after 24 hrs Cl- secretory responses were measured as changes in 
Isc in Ussing chambers. Naive monolayers of cells were then treated for 24 hrs basolaterally with 
conditioned medium from the basolateral side of control and CCh-pretreated cells (n = 6). B - D) 
T84 cell monolayers were pretreated with CCh (100 µM; 15 min) in the absence or presence of B) 
an EGFr inhibitor, tyrphostin AG1478 (100 nM; n = 5), C) a blocking antibody to TGF-α (5 
mg/ml; n = 3) or D) a general inhibitor of metalloproteases, GM 6001 (10 µM; n = 4). After 
treatment with CCh, cells were maintained in the presence of inhibitors alone, or vehicle, for 24 
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hrs before Isc responses to a second challenge with CCh were measured in Ussing chambers. Data 
are expressed as % of vehicle- or inhibitor-treated controls as appropriate. Asterisks denote 
significant differences from control cells that were not pretreated with CCh; * p < 0.05, **p < 
0.01, ***p < 0.001. 
 
Figure 5: Acute stimulation with CCh does not chronically alter M3 receptor expression but 
uncouples the receptor from elevations in intracellular Ca2+. A) Monolayers of T84 cells were 
pretreated with CCh (100 µM) for 15 mins and 24 hrs later cells were lysed and cellular M3 
receptor expression was analyzed by western blotting. Actin expression was measured as a 
loading control (n = 6). B) Cells were pretreated with CCh as described above and M3 receptor 
surface expression was analyzed by basolateral cell surface biotinylation (n = 3). C) T84 cells 
grown on glass coverslips were pretreated with CCh (100 µM) for 15 mins and after 24 hrs CCh-
induced increases in cytosolic Ca2+  were measured by Fura-2 fluorescence. Data are expressed as 
mean fluorescence ratio at 340 and 380 nM (n = 6 coverslips for each condition). The inset shows 
the net change in mean fluorescence ratio (∆F340/380) for these experiments. Asterisks denote 
significant differences from control cells that were not pretreated with CCh; * p < 0.05. 
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